We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Ready-to-Use Urine Chemistry Control Convenient and Inexpensive

By LabMedica International staff writers
Posted on 30 May 2012
A liquid urine control is both easy and convenient for laboratory staff to use. More...
It includes fully assayed target values for 18 commonly performed urine chemistry tests including microalbumin and the hormone human chorionic gonadotropin (hCG), and enables consolidation and cost savings.

The control is manufactured from 100% human urine, not only providing a matrix similar to the patient sample but also reducing antibody interference and the possibility of control values shifting after the reagent batch is changed. A 10 mL vial size and an open vial stability of 30 days at 2-8 °C for all parameters ensure that both waste and costs are kept to a minimum.

Eliminating the need for reconstitution, the liquid stable format of the control reduces the amount of human handling and the subsequent risk of pipetting errors. The material can also be economically shipped and stored at 2-8 °C.

Called the Acusera liquid urine control and manufactured by Randox (Crumlin, United Kingdom), it is compatible for use with Acusera 24.7, the company's new web based inter-laboratory data management program. With 24-7, users benefit from the company's extensive range of data management tools and gain access to worldwide peer-group data. Acusera 24.7 updates peer-group data every 24 hours giving laboratories access to the most up to date information available.

Instrument specific target values and ranges are provided for many common clinical chemistry analyzers including Abbott Architect, and a number of Beckman Coulter and Siemens systems.

Related Links:

Randox



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
New
Automated Coagulation Analyzer
Hemolumi H6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.